Clinical trials sponsored by West China Hospital

Phase breakdown

Conditions studied

Recruiting trials led by West China Hospital

• A Study of GV20-0251 in Advanced or Refractory Solid Tumors
  NCT07106827 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer
  NCT07101679 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• AI App for Management of Atopic Dermatitis
  NCT06362629 · Phase: Not applicable (e.g. observational or device study) · Ages: 1 Year to 75 Years · Sex: All (male and female) · 1 location
• Association Between Early Recurrence and Long-Term Recurrence After Pulsed Field Ablation for Atrial Fibrillation: Prospective Real-World Evidence From China
  NCT07518966 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 Therapy
  NCT07562841 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS
  NCT07612774 · Phase: Phase 4 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 1 location
• Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients
  NCT07510308 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)
  NCT06242418 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 9 locations
• Effect of Lidocaine on Postoperative Pain and Long-term Survival in Elderly Patients Undergoing Colorectal Surgery
  NCT06405776 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · 1 location
• Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)
  NCT06859684 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Identifying Local Field Potential Biomarkers for Obsessive-compulsive Disorder Treatment With Deep Brain Stimulation
  NCT06542224 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 4 locations
• Identifying Local Field Potential Biomarkers for Treatment-Resistant Major Depression With Deep Brain Stimulation
  NCT06542094 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients
  NCT07509333 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 70 Years · Sex: All (male and female) · 1 location
• NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer
  NCT07595172 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
  NCT06341296 · Phase: Phase 2 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy
  NCT07260526 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC
  NCT06627712 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: Female · 1 location
• Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer
  NCT07076823 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer
  NCT04636008 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
  NCT05447702 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• The Outcomes of Living Donor Robotic Assisted Kidney Transplantation
  NCT06577805 · Phase: Not specified · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies
  NCT07763301 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is West China Hospital recruiting for?

West China Hospital is the lead sponsor of 22 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.